MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A Novel Deep Brain Stimulation Programming Paradigm for Parkinson’s disease

J. Karl, L. Verhagen, D. Ocegueda (Chicago, IL, USA)

Meeting: 2017 International Congress

Abstract Number: 377

Keywords: Deep brain stimulation (DBS)

Session Information

Date: Monday, June 5, 2017

Session Title: Surgical Therapy: Parkinson’s Disease

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To report the outcome of a novel interleaving stimulation (ILS) DBS programming paradigm (PP).

Background: DBS of the STN using conventional high frequency (130-185Hz) stimulation (HFS) is more effective in treating appendicular than axial symptoms. In fact, HFS-STN DBS may worsen gait and balance. This could be due to current spread outside the target area (STN) or alternatively HFS may not be the optimal rate for locomotion. Low frequency stimulation (LFS) of the STN has been reported to ameliorate freezing episodes possibly because of the indirect low frequency effect on PPN. However, stimulation at lower frequencies often results in loss of benefit on appendicular symptoms, limiting its clinical usefulness. Medtronic DBS offers an interleaving option which allows delivery of two individual programs on each DBS lead. We took advantage of this option to create a paradigm with two different frequencies.  

Methods: The novel PP (interlink-interleave, IL-IL) consisted of two overlapping LFS programs on each DBS lead, with the overlapping area focused around the optimal electrode contact. Consequently, this area receives HFS which allows for appendicular symptom control, whereas the non-overlapping areas receive LFS to reduce SE, such as dysarthria, and potentially reduce FOG and balance impairment. The amplitude of stimulation was empirically determined by the programmer and the pulse width was left unchanged.  

Results: Thus far 70 PD patients were switched from their optimized conventional HFS settings to the IL-ILS. The majority of patients were stimulated with two bi-polar overlapping programs at (i.e. 0-2+, 1-3+) and the remainder with a combination of mono-polar and bi-polar programs at a frequency of 60-90Hz. 87% of patients remain on the IL-ILS PP after 16 months (range 4-45). Approximately half of this group chose to remain on IL-ILS because of improved dysarthria, balance or gait. The remainder was unable to identify specific improvements, but confirmed their PD symptoms had not deteriorated.

Conclusions: In this preliminary study a significant number of patients chose to remain on IL-ILS because of subjective improvements in balance, gait or dysarthria. Some of those who chose to return to their original HFS settings may have done so before amplitude adjustments had been made. Formal assessment with objective/quantitative outcome measures is under way.  

To cite this abstract in AMA style:

J. Karl, L. Verhagen, D. Ocegueda. A Novel Deep Brain Stimulation Programming Paradigm for Parkinson’s disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/a-novel-deep-brain-stimulation-programming-paradigm-for-parkinsons-disease/. Accessed July 2, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-novel-deep-brain-stimulation-programming-paradigm-for-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley